Normal view MARC view ISBD view

Role for anti-PD-L1 immune checkpoint inhibitor in advanced urothelial carcinoma.

Netto, George J

Role for anti-PD-L1 immune checkpoint inhibitor in advanced urothelial carcinoma. [electronic resource] - Lancet (London, England) May 2016 - 1881-2 p. digital

Publication Type: Journal Article; Comment

ISSN: 1474-547X

Standard No.: 10.1016/S0140-6736(16)00654-1 doi

Subjects--Topical Terms:
Antibodies, Monoclonal--administration & dosage
Antineoplastic Agents--administration & dosage
B7-H1 Antigen--antagonists & inhibitors
Female
Humans
Male
Urologic Neoplasms--drug therapy

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)